- Favorable Aortic Remodeling Following Serial False Lumen Procedures in a Case of Chronic Type IIIb Dissection
-
Eleshra AS, Heo W, Lee KH, Lee SY, Lee H, Song SW
- KMID: 2418588
- Korean J Thorac Cardiovasc Surg.
- 2018 Aug;51(4):286-289.
- doi: 10.5090/kjtcs.2018.51.4.286
We report a case of acute type I aortic dissection in which an emergency graft replacement of the ascending aorta and innominate artery was performed. We performed false lumen thrombosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats
-
Kim HJ, Yoo HY
- KMID: 2364268
- Korean J Physiol Pharmacol.
- 2016 Nov;20(6):641-647.
- doi: 10.4196/kjpp.2016.20.6.641
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by vascular remodeling of pulmonary arteries (PAs) and increased vascular resistance in the lung. Monocrotaline (MCT), a toxic alkaloid, is widely... -
- CITED
-
- Close
- SHARE
-
- Close
- Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and Evolution
-
Capodanno
- KMID: 2405043
- Korean Circ J.
- 2018 Jan;48(1):24-35.
- doi: 10.4070/kcj.2017.0194
Bioresorbable scaffolds (BRS) represent a novel paradigm in the 40-year history of interventional cardiology. Restoration of cyclic pulsatility and physiologic vasomotion, adaptive vascular remodeling, plaque regression, and removal of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Canonical Transient Receptor Potential Channels and Vascular Smooth Muscle Cell Plasticity
-
Nishida M, Tanaka T, Mangmool S, Nishiyama , Nishimura
- KMID: 2470805
- J Lipid Atheroscler.
- 2020 Jan;9(1):124-139.
- doi: 10.12997/jla.2020.9.1.124
Vascular smooth muscle cells (VSMCs) play a pivotal role in the stability and tonic regulation of vascular homeostasis. VSMCs can switch back and forth between highly proliferative (synthetic) and fully... -
- CITED
-
- Close
- SHARE
-
- Close
- Vessel Remodeling after Intima-to-Intima Contact Anastomosis
-
Yeo H, Kim H, Son D, Hong C, Kwon SY
- KMID: 2373083
- Arch Plast Surg.
- 2017 Mar;44(2):95-100.
- doi: 10.5999/aps.2017.44.2.95
BACKGROUND: Intima-to-intima microanastomotic vascular remodeling was explored, utilizing a polylactide-caprolactone absorbable vein coupler model (PAVCM), which was designed to simulate a non-absorbable counterpart system with the sole exception of being... -
- CITED
-
- Close
- SHARE
-
- Close
- Hemoptysis during general anesthesia in a diabetic patient with healed tuberculosis: a case report
-
Chung MY, Jeong HD, Kim SG, Kim CJ
- KMID: 2402901
- Korean J Anesthesiol.
- 2017 Feb;70(1):86-89.
- doi: 10.4097/kjae.2017.70.1.86
Hemoptysis is a common complication of pulmonary tuberculosis. Most of the cases of hemoptysis originate from hypertrophied bronchial arteries. Also, diabetes induces pulmonary vascular abnormalities such as endothelial dysfunction, inflammatory... -
- CITED
-
- Close
- SHARE
-
- Close
- Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor
-
Cha SA, Park BM, Kim SH
- KMID: 2414269
- Korean J Physiol Pharmacol.
- 2018 Jul;22(4):447-456.
- doi: 10.4196/kjpp.2018.22.4.447
Angiotensin-(1-9) [Ang-(1-9)], generated from Ang I by Ang II converting enzyme 2, has been reported to have protective effects on cardiac and vascular remodeling. However, there is no report about... -
- CITED
-
- Close
- SHARE
-
- Close
- Cellular Senescence in Arterial Diseases
-
Shimizu I, Minamino T
- KMID: 2470802
- J Lipid Atheroscler.
- 2020 Jan;9(1):79-91.
- doi: 10.12997/jla.2020.9.1.79
Cell-proliferation potency is limited, as cells cannot proceed through the cell cycle continually. Instead, they eventually show an irreversible arrest of proliferation, commonly referred to as cellular senescence. Following the... -
- CITED
-
- Close
- SHARE
-
- Close
- tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
-
Kim JS
- KMID: 2449893
- J Stroke.
- 2019 May;21(2):160-174.
- doi: 10.5853/jos.2019.00584
Tissue plasminogen activator (tPA) is the only therapeutic agent approved to treat patients with acute ischemic stroke. The clinical benefits of tPA manifest when the agent is administered within 4.5... -
- CITED
-
- Close
- SHARE
-
- Close
